# Trade Mark Journal No.2025/045 7 November 2025

## WO0000001881984 (5)

Office of origin: United States of America

Date of International Registration:23 September 2025
Date of designation in the UK: 23 September 2025

International priority date claimed: 28 March 2025 (United States of America) (99108866)

Class 5
  Pharmaceutical preparations for the treatment and prevention of lymphopenia; pharmaceutical preparations for use in stimulating lymphocyte production; pharmaceutical preparations for maintenance of lymphocyte counts; pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections.

ImmunityBio, Inc.

Representative: Alicia M. Passerin Leech Tishman Fuscaldo & Lampl, 525 William Penn Place, 28th Floor, Pittsburgh PA 15219, UNITED STATES OF AMERICA